Jiangsu, China

Fangzhou Wu

This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Shanghai Hansoh Biomedical Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fangzhou Wu. Retrieved from https://idiyas.com/inventor/fangzhou-wu-a72uowp0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Fangzhou Wu: Innovator in Multi-Receptor Agonist Development

Introduction

Fangzhou Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of multi-receptor agonists. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Fangzhou Wu holds a patent titled "Multi-Receptor Agonist and Medical Use Thereof." This patent highlights his research and development efforts in creating compounds that can interact with multiple receptors, potentially leading to new therapeutic applications.

Career Highlights

Throughout his career, Fangzhou Wu has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd. and Shanghai Hansoh Biomedical Co., Ltd. His experience in these organizations has allowed him to collaborate with leading professionals in the field.

Collaborations

Fangzhou Wu has worked alongside talented individuals such as Lei Wang and Xiao Liu. These collaborations have contributed to his success and the advancement of innovative solutions in the pharmaceutical sector.

Conclusion

Fangzhou Wu's contributions to the field of pharmaceuticals, particularly through his patent on multi-receptor agonists, demonstrate his commitment to innovation and medical advancement. His work continues to inspire future developments in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…